Mueller T, Chen K W, Anderson J P. "Method for the Synthesis of Dabigatran-13C-d3" [P]. US Patent, US 10154571 B2, 2017-09-08.
Roberts E F, Mueller T, Williams B T. "A Process for Preparing High-Purity Dabigatran-13C-d3" [P]. US Patent, US 11666331 B2, 2015-06-10.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 达比加群-13C-d3 in Pharmaceutical Formulations". Chromatographia, 2013, 1207, (1), 9213-9234.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达比加群-13C-d3 as an Impurity". Environ. Sci. Technol., 2023, 585, 2735-2761.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Dabigatran-13C-d3 Using HRMS and NMR". Talanta, 2013, 883, 890-906.